O42: Development of an anti-sense oligonucleotide therapeutic targeting RhoBTB2-related epileptic encephalopathy by Matthew Wheeler, Devon Bonner, Raquel Alvarez, Sara Emami, Richard Coca, Brandon Willis, Hector Mendez, Ruchi Patel, Kate Duong, Jennifer Arthur, Ioannis Karakikes, Jonathan Bernstein, Brenda Porter, Juliet Knowles, Kent Lloyd, Thomas LaRocca

Get full text